Go to the list of all blogs
Anna G's Avatar
published in Blogs
Mar 07, 2022
Cooper (COO, $423.86) beats earnings expectations

Cooper (COO, $423.86) beats earnings expectations

Cooper Companies reported its quarterly earnings results that surpassed analysts’ expectations.

 The medical device company’s earnings came in at $3.24 a share for the quarter, above the Zacks’ consensus estimate of $3.10.  The figure was $3.17 per share a year ago.

Cooper Companies revenue rose +15.7% from the year-ago quarter to  $787.20 million,  also exceeding analyst estimates of $739.30 million.

Looking ahead, Cooper expects its FY 2022 earnings in the range of $13.700-$14.200, and FY22 earnings of $13.70-$14.20 EPS.

Related Ticker: COO

COO in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 05, 2026

COO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where COO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COO as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for COO turned negative on March 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

COO moved below its 50-day moving average on March 04, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for COO crossed bearishly below the 50-day moving average on March 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for COO entered a downward trend on February 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.631) is normal, around the industry mean (8.274). P/E Ratio (34.791) is within average values for comparable stocks, (129.243). Projected Growth (PEG Ratio) (1.824) is also within normal values, averaging (2.343). COO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (3.349) is also within normal values, averaging (59.556).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 10.96B. The market cap for tickers in the group ranges from 246 to 176.23B. ISRG holds the highest valuation in this group at 176.23B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -3%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 8%. PLSE experienced the highest price growth at 20%, while NEPH experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 32%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 69
Price Growth Rating: 66
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
COO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. COO showed earnings on March 05, 2026. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a maker of medical devices

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
6101 Bollinger Canyon Road
Phone
+1 925 460-3600
Employees
15000
Web
https://www.coopercos.com
Interact to see
Advertisement
Dive into the complexities of the miscellaneous sector as we uncover the trajectories of major players like $YETI, $TUP, and $DOV. Despite a significant 20.4% gain in just a month, not everything is as rosy as it seems. Read on to decipher our sell recommendations and where these tickers might be headed next.
Financial Learning Models (FLMs) and machine learning (ML) to operate at unprecedented speeds. These agents, now optimized for 5-minute (M5) timeframes, have demonstrated extraordinary annualized returns, with the top agent exceeding +160%.
AI-Driven Market Insights A.I.dvisor’s latest analysis compares SPY and VOO, two leading ETFs, revealing near-identical year-to-date (YTD) gains of 9.82% for SPY and 9.87% for VOO, a 99% parity.
Tickeron, a leader in AI-driven financial technology, today announced the launch of its advanced AI Trading Agents, delivering real-time trading signals and sophisticated money management for retail and institutional traders. Powered by Financial Learning Models (FLMs) and machine learning, these agents operate across 5-, 15-, and 60-minute timeframes, achieving annualized returns of up to 145% on select portfolios.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, today announced the exceptional performance of its AI Trading Agents, achieving annualized returns of up to 162%, profitable trade percentages as high as 90.51%, and a robust profit factor across multiple assets.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, proudly announces the exceptional performance of its AI Trading Agents, delivering annualized returns of up to 188% on a 5-minute timeframe.
#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, today announced the launch of its advanced Pattern Search Engine (PSE), a revolutionary platform that scans 39 distinct trading patterns across stocks, penny stocks, ETFs, crypto, and forex.
#artificial_intelligence
AI trading bots represent the pinnacle of financial technology innovation, transforming how traders and investors interact with global markets.
#artificial_intelligence
As a financial analyst, writer, and AI specialist, I've always pushed for innovations that merge artificial intelligence with actionable trading tools. In the fast-paced world of modern markets, where volatility demands quick decisions, Tickeron's new "My Trades Aggregator (from AI Robots Followed)" aggregator stands out as a revolutionary feature.
#artificial_intelligence#trading
Tickeron, a leading provider of AI-driven trading solutions, is thrilled to announce the exceptional performance of its AI Trading Agents, delivering outstanding results across multiple high-profile stocks.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technologies, today announced groundbreaking results from its AI Crypto Trading Virtual Agents. These innovative tools provide real-time trading signals, integrated money management, and customizable balances, all powered by advanced machine learning algorithms operating on 5-, 15-, and 60-minute timeframes.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technologies, today announced the launch of its advanced AI Trading Brokerage Agents. These cutting-edge tools deliver real-time trading signals powered by machine learning, utilizing tick-level brokerage data and precise trade amounts across 5-, 15-, and 60-minute timeframes.
#artificial_intelligence
This remarkable rally represents far more than typical market volatility – it signals a fundamental transformation in investor sentiment toward AI connectivity infrastructure and the critical role of semiconductor-based solutions in enabling next-generation artificial intelligence systems
Tickeron, a leader in AI-driven financial tools, today announced the launch of its comprehensive subscription package combining AI Trading Robots for cryptocurrencies with Real-Time Patterns (RTP) analysis.
#artificial_intelligence
Kinross Gold Corporation (KGC), a leading Canada-based gold producer, yielded approximately 2.1 million gold equivalent ounces in 2024.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technologies, today announced impressive results from its AI Trading Agent focused on the iShares U.S. Aerospace & Defense ETF (ITA). Over 123 days, the agent achieved an annualized return of +48%, generating $14,104 in closed trades profit and loss (P/L).
#artificial_intelligence
Tickeron, a pioneer in AI-powered trading solutions, today unveiled groundbreaking results from its 5-minute AI Trading Agent focused on Hubbell Incorporated (HUBB). In just 68 days, the agent delivered an impressive +98% annualized return and $12,899 in closed trades profit/loss (P/L), showcasing the transformative power of machine learning in stock trading.
#artificial_intelligence
In the fast-paced world of stock trading, where market volatility can swing fortunes overnight, Tickeron emerges as a beacon for investors seeking reliable guidance. As a leading provider of AI-powered trading solutions,
#artificial_intelligence
The company's journey from a struggling clean energy stock trading near multi-year lows to a market leader commanding a $12.9 billion valuation demonstrates the convergence of technological breakthroughs, strategic partnerships, regulatory tailwinds, and the explosive growth of AI-driven data centers that require reliable, on-site power solutions.
Palantir Technologies (NASDAQ: PLTR) has delivered one of the most remarkable performances in the technology sector during 2025, with its stock price surging approximately 145% from the April 7, 2025 low of $66.12 to the September 9, 2025 closing price of $162.36.